Clinical Trial Update: A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma [Phase 3]

View source ↗

Summary

This entry describes an ongoing Phase 3 clinical trial comparing niraparib to temozolomide in adults with newly diagnosed MGMT unmethylated glioblastoma. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Niraparib (Niraparib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Ivy Brain Tumor Center | Conditions: Glioblastoma, GBM | Phase 3 | Status: RECRUITING